sr141716 has been researched along with 2-iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1h-indol-3-yl)methanone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akinfeleye, T; Bruneus, M; Deng, H; Dhawan, J; Dimaio, AA; Gatley, SJ; Gifford, AN; Makriyannis, A | 1 |
1 other study(ies) available for sr141716 and 2-iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1h-indol-3-yl)methanone
Article | Year |
---|---|
Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
Topics: Animals; Behavior, Animal; Benzoxazines; Binding Sites; Binding, Competitive; Brain; Cannabinoids; Dose-Response Relationship, Drug; Drug Interactions; Indoles; Iodine Radioisotopes; Male; Mice; Morpholines; Motor Activity; Naphthalenes; Neurons; Piperidines; Protein Conformation; Pyrazoles; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant | 2006 |